BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND ASXL1, ENSG00000171456, 171023, Q8IXJ9, MGC71111, MGC117280, KIAA0978
8 results:

  • 1. Integrative characterization of intraductal tubulopapillary neoplasm (ITPN) of the pancreas and associated invasive adenocarcinoma.
    Mafficini A; Simbolo M; Shibata T; Hong SM; Pea A; Brosens LA; Cheng L; Antonello D; Sciammarella C; Cantù C; Mattiolo P; Taormina SV; Malleo G; Marchegiani G; Sereni E; Corbo V; Paolino G; Ciaparrone C; Hiraoka N; Pallaoro D; Jansen C; Milella M; Salvia R; Lawlor RT; Adsay V; Scarpa A; Luchini C
    Mod Pathol; 2022 Dec; 35(12):1929-1943. PubMed ID: 36056133
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Genomic analysis of familial pancreatic cancers and intraductal papillary mucinous neoplasms: A cross-sectional study.
    Abe K; Kitago M; Kosaki K; Yamada M; Iwasaki E; Kawasaki S; Mizukami K; Momozawa Y; Terao C; Yagi H; Abe Y; Hasegawa Y; Hori S; Tanaka M; Nakano Y; Kitagawa Y
    Cancer Sci; 2022 May; 113(5):1821-1829. PubMed ID: 35238112
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
    Chang S; Yim S; Park H
    Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Momelotinib therapy for myelofibrosis: a 7-year follow-up.
    Tefferi A; Barraco D; Lasho TL; Shah S; Begna KH; Al-Kali A; Hogan WJ; Litzow MR; Hanson CA; Ketterling RP; Gangat N; Pardanani A
    Blood Cancer J; 2018 Mar; 8(3):29. PubMed ID: 29515114
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The oncocytic subtype is genetically distinct from other pancreatic intraductal papillary mucinous neoplasm subtypes.
    Basturk O; Tan M; Bhanot U; Allen P; Adsay V; Scott SN; Shah R; Berger MF; Askan G; Dikoglu E; Jobanputra V; Wrzeszczynski KO; Sigel C; Iacobuzio-Donahue C; Klimstra DS
    Mod Pathol; 2016 Sep; 29(9):1058-69. PubMed ID: 27282351
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Functional proteomics of the epigenetic regulators asxl1, ASXL2 and ASXL3: a convergence of proteomics and epigenetics for translational medicine.
    Katoh M
    Expert Rev Proteomics; 2015 Jun; 12(3):317-28. PubMed ID: 25835095
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Functional and cancer genomics of ASXL family members.
    Katoh M
    Br J Cancer; 2013 Jul; 109(2):299-306. PubMed ID: 23736028
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Identification and characterization of ASXL3 gene in silico.
    Katoh M; Katoh M
    Int J Oncol; 2004 Jun; 24(6):1617-22. PubMed ID: 15138607
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.